FAQ on Nutriband Inc.'s Record Q1 Revenue and AVERSA Fentanyl Development

What contributed to Nutriband Inc.’s record Q1 revenue?

The 63% year-over-year increase to $667,000 was driven by expanded kinesiology tape production through its Pocono Pharma subsidiary and a growing retail presence at major stores like Target, Walmart, Walgreens, and CVS.

What is AVERSA Fentanyl?

AVERSA Fentanyl is an abuse-deterrent transdermal opioid patch developed by Nutriband Inc., incorporating its AVERSA technology to prevent abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.

How is Nutriband advancing the development of AVERSA Fentanyl?

Nutriband has formalized a partnership with Kindeva Drug Delivery to share development costs in exchange for milestone payments as AVERSA moves toward regulatory approval, with projected peak U.S. sales of $80 million to $200 million annually.

Where can I find more information about Nutriband Inc.?

More information about Nutriband Inc. is available on their website at www.Nutriband.com and the latest news and updates are available in the company’s newsroom at https://ibn.fm/NTRB.

What is the significance of Nutriband’s partnership with Kindeva Drug Delivery?

The partnership supports shared development costs for AVERSA Fentanyl in exchange for milestone payments, facilitating the product’s advancement towards regulatory approval and commercial success.

What are the projected sales for AVERSA Fentanyl?

AVERSA Fentanyl is projected to reach peak U.S. sales of $80 million to $200 million annually once it achieves regulatory approval and is commercialized.

How does Nutriband prioritize shareholder value?

Nutriband prioritizes shareholder value by scaling Pocono’s output through penetration pricing strategies and advancing the development of high-potential products like AVERSA Fentanyl.

What is BioMedWire’s role in this context?

BioMedWire is a specialized communications platform that provides news and updates on developments in the Biotechnology, Biomedical Sciences, and Life Sciences sectors, including coverage of Nutriband Inc.’s achievements.